News

News Center

Zhejiang has released the "Implementation Opinions on Accelerating Innovation and Development in Life and Health Technologies (Draft for Comments)," supporting pharmaceutical research and development.

作者：Jiuzhitang Maker, Duan Changsong

来源：Zhejiang Provincial Department of Science and Technology Website

2019-06-05

On May 27, 2019, the Zhejiang Provincial Department of Science and Technology officially released the "Implementation Opinions on Accelerating Innovation and Development in Life and Health Technologies (Draft for Comments)" on its official website. The draft emphasizes strengthening policy support: piloting and advancing cell therapy innovation initiatives in a scientific and prudent manner, starting first in international medical tourism pilot zones, free trade zones, and regions with a solid foundation for development.

It was also mentioned that proactive research in fields such as structural biology, health big data, and cell & immunotherapy will be strengthened to foster interdisciplinary collaboration and drive significant breakthroughs in new discoveries and fundamental principles. By 2022, Zhejiang Province had allocated a special funding package totaling 400–500 million yuan from its fiscal budget to support Westlake University in conducting high-level scientific research. The goal is to establish the university as a world-leading National Center for Biological Structural Sciences, while simultaneously building a world-class Cell Therapy Research Center and a cutting-edge Multi-Omics Big Data Research Center.

Establishing the Fudan University Wenzhou Research Institute, which will focus on building a high-end, industry-focused R&D platform in areas such as innovative macromolecular drugs, stem cells and immune cells, as well as cutting-edge medical devices.

By 2022, a batch of highly innovative, high-value-added products will be developed in key areas such as small-molecule anti-cancer drugs, antibody therapies, protein-based medicines, next-generation vaccines, cell therapy products, advanced implantable/interventional devices, and cutting-edge medical imaging equipment. This effort aims to secure approval for clinical studies or market launch of more than 20 innovative drugs and over 20 Class III medical devices. Additionally, regional cell preparation centers and stem cell clinical research facilities—among other R&D and service platforms—will be established to support these advancements.

Policy Interpretation:

Local governments and industrial parks have enthusiastically responded to the nation’s industrial policies by supporting the biopharmaceutical sector, particularly embracing cutting-edge cell therapy technologies such as immune cell therapy and stem cell treatment. In fact, more developed regions are willing to invest heavily, determined to gain a competitive edge in regional competition.

A Review of Key Policies in the Stem Cell Field for the First Half of 2019

Notice from the State Council on Several Measures to Support Deepening Reform and Innovation in Pilot Free Trade Zones

Here is the title—h1 placeholder text

Online Message

COOKIES

Our website uses cookies and similar technologies to personalize the advertising shown to you and to help you get the best experience on our website. For more information, see our Privacy & Cookie Policy

COOKIES

required

These cookies are necessary for basic functions such as payment. Standard cookies cannot be turned off and do not store any of your information.

analyze

These cookies collect information, such as how many people are using our site or which pages are popular, to help us improve the customer experience. Turning these cookies off will mean we can't collect information to improve your experience.

Feature

These cookies enable the website to provide enhanced functionality and personalization. They may be set by us or by third-party providers whose services we have added to our pages. If you do not allow these cookies, some or all of these services may not function properly.

advertise

These cookies help us understand what you are interested in so that we can show you relevant advertising on other websites. Turning these cookies off will mean we are unable to show you any personalized advertising.

Business license